- Home
- BRIA vs ONCY Comparison
BRIA vs ONCY Comparison
Compare BRIA & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRIA
- ONCY
- Stock Information
- Founded
- BRIA 2011
- ONCY 1998
- Country
- BRIA Singapore
- ONCY Canada
- Employees
- BRIA N/A
- ONCY N/A
- Industry
- BRIA
- ONCY Pharmaceuticals and Biotechnology
- Sector
- BRIA
- ONCY Health Care
- Exchange
- BRIA NYSE
- ONCY Nasdaq
- Market Cap
- BRIA 47.1M
- ONCY 49.1M
- IPO Year
- BRIA 2024
- ONCY 1999
- Fundamental
- Price
- BRIA $2.64
- ONCY $0.34
- Analyst Decision
- BRIA
- ONCY Strong Buy
- Analyst Count
- BRIA 0
- ONCY 4
- Target Price
- BRIA N/A
- ONCY $4.33
- AVG Volume (30 Days)
- BRIA 13.2K
- ONCY 820.6K
- Earning Date
- BRIA 06-10-2025
- ONCY 05-14-2025
- Dividend Yield
- BRIA N/A
- ONCY N/A
- EPS Growth
- BRIA N/A
- ONCY N/A
- EPS
- BRIA 92.24
- ONCY N/A
- Revenue
- BRIA $59,695,825.00
- ONCY N/A
- Revenue This Year
- BRIA N/A
- ONCY N/A
- Revenue Next Year
- BRIA N/A
- ONCY N/A
- P/E Ratio
- BRIA $0.03
- ONCY N/A
- Revenue Growth
- BRIA 8.03
- ONCY N/A
- 52 Week Low
- BRIA $1.78
- ONCY $0.34
- 52 Week High
- BRIA $4.38
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- BRIA N/A
- ONCY 23.40
- Support Level
- BRIA N/A
- ONCY $0.37
- Resistance Level
- BRIA N/A
- ONCY $0.45
- Average True Range (ATR)
- BRIA 0.00
- ONCY 0.04
- MACD
- BRIA 0.00
- ONCY -0.01
- Stochastic Oscillator
- BRIA 0.00
- ONCY 0.50
About BRIA BRILLIA INC
BrilliA Inc is engaged in business of sales and marketing of lingerie's products including bra, panty and body suit, mainly serving the American, European and other markets.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.